Status:
UNKNOWN
Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs
Lead Sponsor:
Peter Vilmann MD, DSc, HC, FASGE
Collaborating Sponsors:
Gastro Unit, Endoscopy Section, Hvidovre Hospital, Denmark
Department of Gastroenterology, Ponderas Academic Hospital Bucharest, Romania
Conditions:
Pancreas Neoplasm
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to compare tissue quality and molecular yield between a novel crown-cut biopsy needle (FNB) and a standard aspiration needle (FNA) for EUS-guided diagnosis of solid pancreatic...
Eligibility Criteria
Inclusion
- Adult patients with a newly discovered SPL scheduled for EUS-guided tissue acquisition who can understand and provide a written consent.
Exclusion
- Patients with uncorrected coagulopathies (INR \>1.5 or platelet count \<50,000) or patients treated with anticoagulants that cannot be discontinued.
- Pregnant or lactating females.
- Interposed, large vessels between the transducer and the target lesion.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04687410
Start Date
June 15 2020
End Date
June 1 2021
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastro Unit, Division of Endoscopy
Herlev, Danmark, Denmark, 2730